Replies to post #1504 on Cytori Therapeutics, Inc. (CYTX)

[UserAlias1]

Cytori to-Provide Corporate-Update at Cowen-and-Company 35(th) Annual Health-Care-Conference

Last update: 03/03/2015 8:00:00 am


Presentation on March 4, 2015 at 8:40 AM Eastern Time

SAN DIEGO--(BUSINESS WIRE)--March 03, 2015--

Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that Dr. Marc H. Hedrick, President and CEO of Cytori Therapeutics, will present at the 35(th) Annual Cowen and Company Health Care Conference in Boston, March 2-5, 2015. Cytori's presentation is scheduled to begin March 4(th) at 8:40 AM Eastern Time, in Salon H, on the 4(th) floor of the Boston Marriott Copley Place. A breakout session will follow at 9:20 AM, in Salon I, on the 4(th) floor.

A live audio webcast of the presentation will be available under the investor relations section of Cytori's website at www.cytori.com. A replay of the presentation will be available for 90 days following the event. Please connect to Cytori's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Cowen and Company's Healthcare Conference

The Annual Cowen and Company Health Care Conference brings together investors and highly regarded healthcare companies from several healthcare related fields. There will be over 250 presenting public and private companies and more than 700 investment managers in attendance.

About Cytori Therapeutics, Inc.

Cytori Therapeutics is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy(TM) acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. As a result, Cytori Cell Therapy(TM) may provide benefits across multiple disease states and can be made available to the physician and patient at the point-of-care through Cytori's proprietary technologies and products. For more information: visit www.cytori.com.

CONTACT: Cytori Therapeutics, Inc.

Shawn Richardson, 1-858-875-5279

[e-mail]

SOURCE: Cytori Therapeutics, Inc.
Copyright Business Wire 2015


(END) Dow Jones Newswires

March 03, 2015 08:00 ET (13:00 GMT)